Cost-Utility of Intermediate Obstetric Critical Care in a Resource-Limited Setting: A Value-Based Analysis

Ann Glob Health. 2020 Jul 20;86(1):82. doi: 10.5334/aogh.2907.

Abstract

Background: Sierra Leone faces among the highest maternal mortality rates worldwide. Despite this burden, the role of life-saving critical care interventions in low-resource settings remains scarcely explored. A value-based approach may be used to question whether it is sustainable and useful to start and run an obstetric intermediate critical care facility in a resource-poor referral hospital. We also aimed to investigate whether patient outcomes in terms of quality of life justified the allocated resources.

Objective: To explore the value-based dimension performing a cost-utility analysis with regard to the implementation and one-year operation of the HDU. The primary endopoint was the quality-adjusted life-years (QALYs) of patients admitted to the HDU, against direct and indirect costs. Secondary endpoints included key procedures or treatments performed during the HDU stay.

Methods: The study was conducted from October 2, 2017 to October 1, 2018 in the obstetric high dependency unit (HDU) of Princess Christian Maternity Hospital (PCMH) in Freetown, Sierra Leone.

Findings: 523 patients (median age 25 years, IQR 21-30) were admitted to HDU. The total 1 year investment and operation costs for the HDU amounted to €120,082 - resulting in €230 of extra cost per admitted patient. The overall cost per QALY gained was of €10; this value is much lower than the WHO threshold defining high cost effectiveness of an intervention, i.e. three times the current Sierra Leone annual per capita GDP of €1416.

Conclusion: With an additional cost per QALY of only €10.0, the implementation and one-year running of the case studied obstetric HDU can be considered a highly cost-effective frugal innovation in limited resource contexts. The evidences provided by this study allow a precise and novel insight to policy makers and clinicians useful to prioritize interventions in critical care and thus address maternal mortality in a high burden scenario.

MeSH terms

  • Administration, Intravenous
  • Adult
  • Anti-Bacterial Agents / therapeutic use
  • Anticonvulsants / therapeutic use
  • Antihypertensive Agents / therapeutic use
  • Blood Transfusion
  • Cost-Benefit Analysis
  • Critical Care / economics*
  • Critical Care / methods
  • Critical Care / organization & administration
  • Female
  • Health Resources
  • Hospital Units / economics*
  • Hospitals, High-Volume
  • Hospitals, Maternity / economics*
  • Hospitals, Maternity / organization & administration
  • Hospitals, Urban
  • Humans
  • Intensive Care Units
  • Length of Stay
  • Magnesium Sulfate / therapeutic use
  • Maternal Mortality*
  • Obstetric Labor Complications
  • Obstetrics
  • Oxygen Inhalation Therapy
  • Patient Transfer
  • Pregnancy
  • Pregnancy Complications / mortality
  • Pregnancy Complications / therapy*
  • Quality-Adjusted Life Years*
  • Retrospective Studies
  • Seizures / prevention & control
  • Sierra Leone
  • Vasoconstrictor Agents / therapeutic use
  • Young Adult

Substances

  • Anti-Bacterial Agents
  • Anticonvulsants
  • Antihypertensive Agents
  • Vasoconstrictor Agents
  • Magnesium Sulfate